Status:
COMPLETED
Using an iPhone ECG to Monitor the QT Interval on Dofetilide and Sotalol Patients
Lead Sponsor:
University of Oklahoma
Conditions:
Cardiac Arrhythmia
Qt Interval, Variation in
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will validate the recording accuracy of a specific electrical interval of the heart, the QT interval, between an iPhone rhythm strip recording and a traditional 12-lead electrocardiogram (E...
Detailed Description
Patients that were already selected to begin either dofetilide or sotalol in the hospital, will be included in the study. Patients will receive an ECG before and 2 hours after each dose of the medicat...
Eligibility Criteria
Inclusion
- initiation of sotalol or dofetilide
- inpatient at University hospital
Exclusion
- none
Key Trial Info
Start Date :
September 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2015
Estimated Enrollment :
29 Patients enrolled
Trial Details
Trial ID
NCT02241252
Start Date
September 1 2013
End Date
May 1 2015
Last Update
May 29 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States, 73104